Stay updated on Ruxolitinib in COVID Cytokine Storm Clinical Trial

Sign up to get notified when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ruxolitinib in COVID Cytokine Storm Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added the RUXCOVID Lancet Rheumatol 2022 publication citation with full author list and DOI. Removed the Lancet Rheumatol 2024 erratum notice.
    Difference
    0.3%
    Check dated 2025-11-03T12:42:27.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Updated citation (with erratum) and operating status notice added; older citation and earlier revision removed. The page now references the corrected citation version (v3.2.0) and includes current government operating status information.
    Difference
    3%
    Check dated 2025-10-05T17:28:09.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Added revision v3.1.0; removed several drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while updating version from v3.0.2 to v3.1.0.
    Difference
    0.3%
    Check dated 2025-09-28T10:15:14.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.1%
    Check dated 2025-09-14T00:33:51.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-06T21:23:28.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new facility names and locations across various countries, while also removing outdated location references. Notably, the content related to drug safety and pathological conditions has been expanded.
    Difference
    6%
    Check dated 2025-08-30T15:53:16.000Z thumbnail image

Stay in the know with updates to Ruxolitinib in COVID Cytokine Storm Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.